TorstenPeterVahlMD
Cardiology • New York, NYAdult Congenital Heart Disease, Interventional Cardiology
Physician
Overview of Dr. Vahl
Dr. Torsten Vahl is a cardiologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and NewYork-Presbyterian/Lawrence Hospital. He received his medical degree from Philipps University of Marburg Faculty of Medicine and has been in practice 19 years. He is one of 697 doctors at New York-Presbyterian Hospital and one of 322 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Cardiology. He has more than 100 publications and over 500 citings.
Office
177 Fort Washington Ave
5TH floor 5C501
New York, NY 10032
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 2008 - 2012- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2006 - 2008
Philipps University of Marburg Faculty of MedicineClass of 1998
Certifications & Licensure
NY State Medical License 2011 - 2025- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- 263 citationsGlucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats.Torsten P. Vahl, Miyuki Tauchi, Timothy S. Durler, Eileen E. Elfers, Timothy M. Fernandes
Endocrinology. 2007-10-01 - 9 citationsLong-Term Outcomes of Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease.Takuya Ogami, Paul Kurlansky, Hiroo Takayama, Yuming Ning, Ziad A. Ali
Journal of the American Heart Association. 2021-08-17 - 22 citationsTemporal Trends in Quality of Life Outcomes After Transapical Transcatheter Aortic Valve Replacement A Placement of AoRTic TraNscathetER Valve (PARTNER) Trial SubstudyHemal Gada, Ajay J. Kirtane, Kaijun Wang, Yang Lei, Elizabeth A. Magnuson
Circulation. Cardiovascular Quality and Outcomes. 2015-06-09
Journal Articles
- Focus on Trends in Surgical and Transcatheter Aortic Valve Replacement Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Prior Cardiac Surgery in...Vinod H Thourani, Lars Svensson, Kevin L Greason, Torsten P Vahl, Rakesh M Suri, Martin B Leon, Susheel K Kodali, Tamim Nazif, ScienceDirect
Lectures
- Case: JenaValve for Pure Aortic RegurgitationCRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
- The Anatomically 'Correct' JenaValve TAVR System – Best for Pure AR and Low Coronaries – EFS ResultsCRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
- Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary OcclusionCRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
- Join now to see all
Press Mentions
ALIGN-AR at 2 Years Shows Promise for TAVI with Trilogy in Aortic RegurgitationOctober 29th, 2024- New Study Aims to Show Effectiveness of CRT-D for Heart Failure Patients with Atrial FibrillationAugust 3rd, 2021
TAVR Expected to See Rapid Growth in Next 5 YearsFebruary 24th, 2020- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
